Profil
James A. Vollins worked as Secretary & Chief Compliance Officer at Bio Products Laboratory Ltd. from 2014 to 2018.
Then, served as Secretary & Chief Compliance Officer at BioDelivery Sciences International, Inc. from 2018 to 2022.
Most recently, held the position of Secretary & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. from 2023 to 2024.
Education includes undergraduate studies at Wesleyan University and graduate studies at Case Western Reserve University School of Law.
Anciens postes connus de James Vollins
| Sociétés | Poste | Fin |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Compliance Officer | 01/01/2024 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Compliance Officer | 22/03/2022 |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Produces human blood plasma products to treat neurological & immunodeficiency and coagulation diseases | Compliance Officer | 01/10/2018 |
Formation de James Vollins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Produces human blood plasma products to treat neurological & immunodeficiency and coagulation diseases | Health Technology |
Case Western Reserve University School of Law
Case Western Reserve University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
















